Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Cost-Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness
2024
· University of Michigan,
· Centers for Disease Control and Prevention (CDC),
· U.S. Public Health Service
This study evaluates the benefits and cost-effectiveness of a vaccine for pregnant women to protect babies from RSV, a virus that can cause serious illness …
Ask aRCie
Nirsevimab Coverage, Children 0 to 7 months, United States
The report describes how nirsevimab coverage for infants 0 to 7 months is tracked in the U.S. using data from Immunization Information Systems (IIS). It …
Notes from the Field: Rollout of Nirsevimab to Protect Infants and Young Children During the Respiratory Syncytial Virus Season — New York City, 2023–2024
2024
· New York City Department of Health and Mental Hygiene,
· Centers for Disease Control and Prevention (CDC)
This analysis reviewed nirsevimab dosing based on Vaccines for Children (VFC) eligibility in New York City during the 2023–24 RSV season. A nirsevimab shortage in …
Recommended Childhood and Adolescent Immunization Schedule: United States, 2024
This policy statement describes the 2024 recommended childhood and adolescent immunization schedules, approved by multiple medical organizations including the CDC and AAP. Updates include the …
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower RespiratoryTract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United Sta
This article discusses the use of Pfizer's RSV vaccine for pregnant women to protect infants from RSV-related lung disease. The CDC recommends giving the vaccine …
Indian Health Service Nirsevimab Vaccine Update
2024
· Indian Health Service
This document provides information on nirsevimab and recommendations for its use, including an administration visual guide. It addresses the documentation of administered doses and reconciliation …
Nirsevimab Administration Visual Guide
This 2-page infographic includes a flowchart to aid in making decisions about nirsivemab administration and dosing in infants and toddlers. It provides immunization administration tips, …
Drug Trials Snapshots: BEYFORTUS
This webpage features a drug trial snapshot for the drug Beyfortus, a monoclonal antibody given as an injection to protect against RSV. Snapshots reveal participants …
Nirsevimab
This webpage features the drug dictionary entry for nirsevimab, providing the National Cancer Institute's definition. It describes nirsevimab as a special type of medicine called …
ACIP Evidence to Recommendations for Use of Nirsevimab in Children 8–19 Months of Age at Increased Risk of Severe Disease Entering Their Second RSV Season
This webpage provides evidence for the recommendations made by the Advisory Committee on Immunization Practices (ACIP) for the use of nirsevimab for a population of …